Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research ...

Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report ...

Stryker has entered a definitive agreement to acquire complete issued and outstanding shares of Inari Medical’s common stock ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired ...

Massachusetts agtech startup Inari Agriculture Inc. said it raised $144 million of new equity at a $2.17 billion valuation, a ...

Stryker is in advanced discussions to acquire Inari Medical, a company producing devices for venous diseases. If successful, the acquisition, valued at nearly $3 billion, would enhance Stryker's ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Inari Medical (NARI – Research Report) yesterday and set a price target of ...

Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for ...

Stryker has announced a $4.9 billion acquisition of Inari Medical, a move set to enhance its offerings for treating venous diseases. The acquisition positions Stryker to better serve patients with ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cencora (COR – Research Report) and Inari ...